EE200200671A - Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks - Google Patents

Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks

Info

Publication number: EE200200671A
Authority: EE; Estonia
Prior art keywords: hygromycin; bacterial; derivatives; treatment; protozoal infections
Prior art date: 2000-06-02

Application number

EEP200200671A

Other languages

English (en)

Estonian (et)

Inventor

Merrill Hayward Matthew

Gerald Linde Ii Robert

Kaneko Takushi

Scott Visser Michael

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-25

Publication date

2004-08-16

2001-05-25 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2004-08-16 Publication of EE200200671A publication Critical patent/EE200200671A/xx

Links

208000035143 Bacterial infection Diseases 0.000 title 1
206010037075 Protozoal infections Diseases 0.000 title 1
230000001580 bacterial effect Effects 0.000 title 1
208000022362 bacterial infectious disease Diseases 0.000 title 1
YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical class O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200200671A 2000-06-02 2001-05-25 Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks EE200200671A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20902300P	2000-06-02	2000-06-02
PCT/IB2001/000946 WO2001092280A1 (fr)	2000-06-02	2001-05-25	Derives de l'hygromycine a pour le traitement d'infections bacteriennes et protozooses

Publications (1)

Publication Number	Publication Date
EE200200671A true EE200200671A (et)	2004-08-16

Family

ID=22777009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200671A EE200200671A (et)	2000-06-02	2001-05-25	Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks

Country Status (31)

Country	Link
US (1)	US6867230B2 (fr)
EP (1)	EP1287011A1 (fr)
JP (1)	JP2003535100A (fr)
KR (1)	KR20030010655A (fr)
CN (1)	CN1432019A (fr)
AP (1)	AP2002002669A0 (fr)
AR (1)	AR028667A1 (fr)
AU (1)	AU2001260528A1 (fr)
BG (1)	BG107265A (fr)
BR (1)	BR0111242A (fr)
CA (1)	CA2410643A1 (fr)
CZ (1)	CZ20023859A3 (fr)
EA (1)	EA200201167A1 (fr)
EC (1)	ECSP014093A (fr)
EE (1)	EE200200671A (fr)
GT (1)	GT200100099A (fr)
HU (1)	HUP0302263A2 (fr)
IL (1)	IL152984A0 (fr)
IS (1)	IS6618A (fr)
MA (1)	MA26909A1 (fr)
MX (1)	MXPA02011966A (fr)
NO (1)	NO20025704D0 (fr)
OA (1)	OA12277A (fr)
PA (1)	PA8518101A1 (fr)
PE (1)	PE20020334A1 (fr)
PL (1)	PL359179A1 (fr)
SK (1)	SK16612002A3 (fr)
SV (1)	SV2002000474A (fr)
TN (1)	TNSN01080A1 (fr)
UY (1)	UY26741A1 (fr)
WO (1)	WO2001092280A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003097573A1 (fr)	2002-05-16	2003-11-27	Sepracor, Inc.	Amines inhibant un transporteur d'anandamide de type mammalien, et procedes d'utilisation
CA3110075A1 (fr) *	2018-08-20	2020-02-27	Northeastern University	Composes d'hygromycine a et procedes de traitement de maladies a spirochetes
CU20180159A7 (es) *	2018-12-28	2020-10-20	Chengdu Olisynn Biotechnology Co Ltd	Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1234567A (en) *	1915-09-14	1917-07-24	Edward J Quigley	Soft collar.
US2004123A (en) *	1934-02-15	1935-06-11	Jr Robert B Loibl	Pest exterminator
AU762302B2 (en) *	1998-05-04	2003-06-19	Pfizer Products Inc.	2"-deoxy hygromycin derivatives
GT199900064A (es) *	1998-05-04	2000-10-24	Pfizer Prod Inc	Derivados de higromicina a.
EE200100301A (et) *	1998-12-02	2002-08-15	Pfizer Products Inc.	Hügromütsiin A derivaadid kui antibakteriaalsed ühendid
HK1049672A1 (zh) *	1999-10-29	2003-05-23	辉瑞产品公司	潮霉素衍生物
US7654321B2 (en) *	2006-12-27	2010-02-02	Schlumberger Technology Corporation	Formation fluid sampling apparatus and methods

2001
- 2001-05-25 EE EEP200200671A patent/EE200200671A/xx unknown
- 2001-05-25 EP EP01934231A patent/EP1287011A1/fr not_active Withdrawn
- 2001-05-25 KR KR1020027016396A patent/KR20030010655A/ko not_active Ceased
- 2001-05-25 CN CN01810623A patent/CN1432019A/zh active Pending
- 2001-05-25 OA OA1200200361A patent/OA12277A/en unknown
- 2001-05-25 HU HU0302263A patent/HUP0302263A2/hu unknown
- 2001-05-25 AP APAP/P/2002/002669A patent/AP2002002669A0/en unknown
- 2001-05-25 CA CA002410643A patent/CA2410643A1/fr not_active Abandoned
- 2001-05-25 JP JP2002500893A patent/JP2003535100A/ja not_active Withdrawn
- 2001-05-25 CZ CZ20023859A patent/CZ20023859A3/cs unknown
- 2001-05-25 IL IL15298401A patent/IL152984A0/xx unknown
- 2001-05-25 EA EA200201167A patent/EA200201167A1/ru unknown
- 2001-05-25 MX MXPA02011966A patent/MXPA02011966A/es not_active Application Discontinuation
- 2001-05-25 WO PCT/IB2001/000946 patent/WO2001092280A1/fr not_active Ceased
- 2001-05-25 BR BR0111242-2A patent/BR0111242A/pt not_active IP Right Cessation
- 2001-05-25 PL PL01359179A patent/PL359179A1/xx not_active Application Discontinuation
- 2001-05-25 AU AU2001260528A patent/AU2001260528A1/en not_active Abandoned
- 2001-05-25 SK SK1661-2002A patent/SK16612002A3/sk unknown
- 2001-05-30 PA PA20018518101A patent/PA8518101A1/es unknown
- 2001-05-30 GT GT200100099A patent/GT200100099A/es unknown
- 2001-05-31 UY UY26741A patent/UY26741A1/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102642A patent/AR028667A1/es unknown
- 2001-06-01 US US09/872,731 patent/US6867230B2/en not_active Expired - Fee Related
- 2001-06-01 TN TNTNSN01080A patent/TNSN01080A1/fr unknown
- 2001-06-01 EC EC2001004093A patent/ECSP014093A/es unknown
- 2001-06-01 PE PE2001000511A patent/PE20020334A1/es not_active Application Discontinuation
- 2001-06-01 SV SV2001000474A patent/SV2002000474A/es not_active Application Discontinuation
2002
- 2002-11-12 BG BG107265A patent/BG107265A/bg unknown
- 2002-11-14 IS IS6618A patent/IS6618A/is unknown
- 2002-11-27 NO NO20025704A patent/NO20025704D0/no not_active Application Discontinuation
- 2002-11-29 MA MA26928A patent/MA26909A1/fr unknown

Also Published As

Publication number	Publication date
SK16612002A3 (sk)	2004-04-06
AR028667A1 (es)	2003-05-21
WO2001092280A1 (fr)	2001-12-06
IS6618A (is)	2002-11-14
NO20025704L (no)	2002-11-27
HUP0302263A2 (hu)	2003-10-28
SV2002000474A (es)	2002-07-03
PE20020334A1 (es)	2002-04-30
CA2410643A1 (fr)	2001-12-06
IL152984A0 (en)	2003-06-24
PA8518101A1 (es)	2002-09-17
BG107265A (bg)	2003-07-31
MXPA02011966A (es)	2003-04-22
US6867230B2 (en)	2005-03-15
TNSN01080A1 (fr)	2005-11-10
NO20025704D0 (no)	2002-11-27
PL359179A1 (en)	2004-08-23
UY26741A1 (es)	2001-12-28
US20030045528A1 (en)	2003-03-06
CN1432019A (zh)	2003-07-23
BR0111242A (pt)	2003-06-03
ECSP014093A (es)	2002-01-25
MA26909A1 (fr)	2004-12-20
CZ20023859A3 (cs)	2004-02-18
EP1287011A1 (fr)	2003-03-05
EA200201167A1 (ru)	2003-06-26
KR20030010655A (ko)	2003-02-05
GT200100099A (es)	2002-01-31
OA12277A (en)	2006-05-11
JP2003535100A (ja)	2003-11-25
AU2001260528A1 (en)	2001-12-11
AP2002002669A0 (en)	2002-12-31

Publication	Publication Date	Title
DE60029883D1 (de)	2006-09-21	Medizinischer Vernebler
PL376454A1 (en)	2005-12-27	1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU6174900A (en)	2001-01-30	Use of flavones, coumarins and related compounds to treat infections
NO20015464L (no)	2001-11-08	Attenuerte mikroorganismer for behandling av infeksjon
NO20005839D0 (no)	2000-11-17	Preparater for behandling av HIV og andre virale infeksjoner
NO20025204D0 (no)	2002-10-30	Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
AU2001269704A1 (en)	2002-01-21	Oxazinoquinolones useful for the treatment of viral infections
AU2281601A (en)	2001-07-03	Treatment of viral infections using levovirinTM
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
PT1220858E (pt)	2004-03-31	Oxazinoquinolonas uteis para o tratamento de infeccoes virais
EE200200671A (et)	2004-08-16	Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks
NO20013651D0 (no)	2001-07-25	Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20032769D0 (no)	2003-06-18	Kombinasjonsmetode for behandling av virale infeksjoner
AU2002239395A1 (en)	2002-06-03	Hiv treatment with benzimidazoles
AU4145999A (en)	1999-12-13	Topical drug for the treatment of viral infections
NO20022949D0 (no)	2002-06-19	Attenuerte mikroorganismer for behandling av infeksjon
AU2001258675A1 (en)	2001-11-26	Treating infections
EP1143941A3 (fr)	2002-02-06	Utilisation de 3-isoxazolidinones et d'hydroxylaminoacides pour le traitement d'infections
AU2002251202A1 (en)	2002-10-15	Intimins for the prevention or treatment of infections: i
AU3524700A (en)	2000-09-28	Prevention and treatment of viral infections
AU2002360523A1 (en)	2003-06-23	Compounds to treat hiv infection and aids
AU2001282277A1 (en)	2002-02-18	Treatment of mycobacterial infection
AU1392601A (en)	2001-05-14	Prevention and treatment of biomaterial-associated infections
AU1673200A (en)	2000-07-12	Medicaments for the treatment of lung infections
AU3397301A (en)	2001-09-03	Treatment of hookworm infection